U.S. Overactive Bladder Market

Published by: Frost & Sullivan

Published: Nov. 13, 2009 - 83 Pages

Table of Contents

1. Executive Summary

U.S. Overactive Bladder Market

Introduction

2. Market Introduction Research

Scope and Methodology

Scope and Segmentation

Research Methodology

Market Overview

Market Engineering Measurements

Disease Overview

Treatment Options

Patient Forecasts

Industry Challenges

Market Drivers

Market Restraints

Product Analysis

Product Analysis

Product Comparisons

Recently Approved Products

Pipeline Analysis

Phase III

Phase II

Phase I

3. Competitive Analysis

Overview

Competitive Structure

Forecasts and Trends

Total Market

Revenue Forecasts by Product

Market Share Analysis

Company Market Share

Product Market Share

Drug Delivery Market Share

4. Appendix

Decision Support Databases

Population 65 Plus

Female Population 65 Plus

Male Population 65 Plus

Total Life Expectancy at Birth

Birth Rate

Abstract

This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.